Infections and melanoma risk: Results of a multicentre EORTC case- control study

Melanoma Research

Volumn 9, Issue 5, 1999, Pages 511-519

  Kolmel K F ^a   Pfahlberg, A ^b   Mastrangelo, G ^c   Niin, M ^d   Botev, I N ^e   Seebacher, C ^f   Schneider, D ^b   Lambert, D ^g   Shafir, R ^h   Kokoschka, E M ⁱ   Kleeberg, U R ^j   Henz, B M ^k   Gefeller, O ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Istituto di Medicina Clinica Padova   (Italy)

^d Institute of Experimental and Clinical Medicine Tallinn   (Estonia)

^e UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^f ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^g DIJON UNIVERSITY HOSPITAL   (France)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j Praxis Altona   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Epidemiology; Febrile infection; Melanoma

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FEVER; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFLUENZA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PNEUMONIA; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; SHWARTZMAN PHENOMENON; SKIN CARCINOGENESIS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE ACTIVATION;

EID: 0032697501     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199910000-00011     Document Type: Article

References (47)

1. Greene MH, Young TI. Malignant melanoma in renal transplant recipients. Lancet 1981; i: 1196-1198.
2. Autier P, Doré JF, Lejeune F, et al. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium. France and Germany, Int J Cancer 1994; 58: 809-813.
3. Elwood MM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997; 73: 198-203.
4. Stern RS, Nichols KT, Väkevä I.H. Malignant melanoma in patients treated for psoriasis with Methoxsalen (Psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997: 336: 1041-1045.
5. Schmidt R. Krebs und Infektionskrankheiten. Med Klin 1910; 43: 1690-1693.
6. Braunstein A. Krebs und Malaria. Z Krebsforsch 1929; 29: 330-331.
7. Ungar FH. Problem of allergy and malignant tumors. Acta Unio Int Contra Cancrum 1953; 9: 213-216.
8. Kofler E, Hussarek M. Konstitutionelle Faktoren bei Rhinitis vasomotoria. Nasenpolypen und Carcinomanasi. Krebsarzt 1954; 9: 89-94.
9. Schulz G. Verhütet Fieber Karzinome? Münch Med Wochenschr 1969; 111: 1051-1052.
10. Engel R Über den Infektionsindex der Krebskranken. Wien Klin Wochenschr 1934; 47: 1118-1119.
11. Sinek E Versuch einer statistischen Erfassung endogener Faktoren bei Carcinomkranken. Z Krebsforsch 1936; 44: 492-527.
12. Witzel L. Anamnese und Zweiterkrankungen bei Patienten mit bösartigen Neubildungen. Med Klin 1970; 65: 876-879.
13. Gruffermann S, Wang HH, Delong ER, et al Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst 1982; 68: 107-113.
14. Remy W, Hammerschmidt K, Zänker KS, et al. Tumorträger haben selten Infekte in der Anamnese. Med Klin 1983; 78: 95-98.
15. Chilvers C, Johnson B, Leach S, et al. The common cold allergy, and cancer. Br J Cancer 1986; 54: 123126.
16. Van Steensel-Moll HA, Valkenburg HA, van Zanen GE. Childhood leukemia and infectious diseases in the first year of life: a register-based case-control study. Am J Epidemiol 1986; 124: 590-594.
17. Abel U, Becker N, Angerer R, et al. Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 1991; 117: 339-344.
18. Grossarth-Maticek R, Frentzel-Beyme R, Kanazir D, et al. Reported herpes-virus-infection, fever and cancer incidence in a prospective study. J Chronic Dis 1987; 40: 967-976.
19. Kölmel KF, Gefeller O, Haferkamp B. Febrile infections and malignant melanoma: results of a case-control study. Melanoma Res 1992; 2: 207-211.
20. Smith JAE, Whatley PM, Redburn JC, EUROCARE Working Group. Improving survival of melanoma patients in Europe since 1978. Eur J Cancer 1998; 34; 2197-2203.
21. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
22. Gallagher RP, McLean DI, Yang P, et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch Dermatol 1990; 126: 770-776.
23. Hasday JD. The influence of temperature on host defenses. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. Philadelphia: Lippincott-Raven, 1997: 177-196.
24. Breslow NE, Day NE, Statistical Methods in Cancer Research, Vol. 1. The Analysis of Case-Control Studies. Lyon: IARC Science Publications, 1980.
25. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
26. Stokes ME, Davis CS, Koch GC. Categorical Data Analysis Using the SAS System. Gary, North Carolina: SAS Institute Inc, 1995.
27. Evans RD, Kopf AW, Lew RA, et al. Risk factors for the development of malignant melanoma I: review of case-control studies. J Dermatol Surg Oncol 1988; 14: 393-408.
28. Wacholder S, Silverman DT, From L, et al. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 1990; 131: 232-243.
29. Gefeller O, Pfahlberg A, Brenner H, Windeler J. An empirical investigation on matching in published case-control studies. Eur J Epidemiol 1998; 14: 321-325.
30. Caygill CPJ, Hill MJ, Braddick M, Sharp JCM. Cancer mortality in chronic typhoid and paratyphoid carriers. lancet 1994; 343: 83-84.
31. De Koster E, Buset M, Fernandes E, Deltenre M. Helicobacter pylori: the link with gastric cancer. Eur J Cancer Prev 1994; 3: 247-257.
32. Morris JDH, Eddleston ALWF, Crook T. Viral infection and cancer. Lancet 1995; 346: 754-758.
33. Grange JM, Stanford JL, Rook GAW. Tuberculosis and cancer: parallels in host responses and therapeutic approaches? Lancet 1995; 345: 1350-1352.
34. Cohen IR, Young DB. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991; 12: 105-110.
35. Ullrich SJ, Robinson EA, Law LW, et al. A mouse tumour-specific transplantation antigen is a hear shock-regulated protein. Proc Natl Acad Sci USA 1986; 83: 3121-3125.
36. Srivastava PK, Stress-induced protein in immune response to cancer. Curr Topics Microbiol Immunol 1991; 167: 109-123.
37. Hernandez-Pando R, Rook GAW. The role of TNFα in T cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 1991; 82: 591-595.
38. Everson TC, Cole WH. Spontaneous Regression of Cancer. London: WB Saunders, 1966.
39. Maurer S, Kölmel KF. Spontaneous Regression of Malignant Melanoma. New York: Cancer Research Institute, 1997.
40. Nauts HC. Bibliography of Reports Concerning the Clinical and Experimental Use of Coley's Toxins (Streptococcus pyogenes and Scrratia marcescens) 1983-1990. New York: Cancer Research Institute, 1990.
41. Starnes CO, Coley's toxins in perspective. Nature 1992:357: 11-12.
42. Chen L. Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol Today 1998; 19:27-30.
43. Itaya T, Fearon E, Fiesinger T. et al, Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes. Cancer Immunol Immunother 1991; 33: 267-273.
44. Pardoll DM. Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol 1995; 13: 399-415.
45. Kaplan DH. Shankaran V, Dighe AS, et al. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 1998:95:7556-7561.
46. Mastrangelo G, Marzia V, Marcer G. Reduced lung cancer mortality in dairy farmers: is endotoxin exposure the key factor? Am J Industr Med 1996; 30: 601-609.
47. Yamakido M, Ishioka S, Hiyama K, Maeda A. Former poison gas workers and cancer: incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS. I'nviron Health Perspect 1996; 104 (suppl): 485-488.